UAB Hospital Highlands
Birmingham, Alabama, 35205, United States
Location status: Recruiting
Location contact
Amit Momaya, MD
CONTACT
Audria Wood, MPH
SUB_INVESTIGATOR
Elizabeth M Benson, MS
SUB_INVESTIGATOR
NCT Number: NCT05461326
The choice of autograft for ACL reconstruction continues to be debated. To date, there has only be one completed randomized controlled trial with quad tendon to BTB and the tendon included a bone plug. There has been no study to date comparing an all soft tissue quad tendon to patellar tendon in a randomized controlled trial for ACL reconstruction.
Interested in participating?
Request Info14 year–65 year
All sexes
Interventional
Not applicable
Birmingham, Alabama, 35205, United States
Location status: Recruiting
Amit Momaya, MD
CONTACT
Audria Wood, MPH
SUB_INVESTIGATOR
Elizabeth M Benson, MS
SUB_INVESTIGATOR
Patients will be recruited from the PI's population base at Highlands Sports Medicine Clinic. Patients in need of an ACL reconstruction will be asked if they are interested in participating in a study comparing BTB and QT autografts by the PI (Dr. Amit Momaya). The benefits and risks of each graft choice will be thoroughly explained. Both graft options are considered equally appropriate management. Interested patients will be screened for eligibility criteria by a research assistant; those matching eligibility will be consented and enrolled in person at the time of the visit.
Patients will be randomized per trial arm assignment to either (i) assignment "0" or (ii) assignment "1". To ensure randomization, a random number generator is used to assign patient numbers and study groups; these assignments are placed with consent information to remain blinded to research personnel and participants until the consent and enrollment process. We anticipate fifty participants per assignment and oen-hundred participants in total. Assignment 0 represents the BTB group. This procedure harvests the patient's middle third of the patella tendon through a single incision for the new ACL graft. When the graft is in place, the graft is secured using a surgical button at the femoral end and a non-absorbable screw at the tibial end. Assignment 1 represents the QT group. This procedure harvests the patient's quadricep tendon through a single incision then utilizes surgical buttons to fix the graft at the tibial and femoral ends. Following enrollment, patients will immediately be notified of their assignment. Patients will also complete KT-1000 manual maximum side-to-side difference measurements . The patient will then be scheduled for ACL reconstruction surgery according to their assignment.
Following reconstruction, standard of care rehabilitation and mobility instructions will be provided. Participants are expected to complete the usual standard of care 2 week, 6 week, 3 month, 6 month, and 9 month postoperative appointments. At the 2 week and 9 month postoperative visits, a routine x-ray will be performed. Aside from a singular KT-1000 measurement and repeated surveys, the patient should not expect any differences in their postoperative visits compared to if they had not participated in the study.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
quadriceps tendon autograft
patellar tendon autograft
Time frame: Operative Day, 9 Months Post-Operative Clinic Visit
Measures maximum side-to-side difference of laxity (translation of the tibia in comparison to a fix femur)
Time frame: 6 weeks, 3 months, 6 months, 9 months, 12 months, and 24 months post-operative assessment
The International Knee Documentation Committee Subjective Knee Evaluation Form measures symptoms, function, and sports activity of people with a variety of knee disorders, including ligamentous and meniscal injuries, osteoarthritis, and patellofemoral dysfunction. Normative values have been published for comparison.
Time frame: 6 weeks, 3 months, 6 months, 9 months, 12 months, and 24 months post-operative assessment
This survey evaluates short-term and long-term symptoms and function in subjects with knee injury and osteoarthritis
Time frame: 6 weeks, 3 months, 6 months, 9 months, 12 months, and 24 months post-operative assessment
This survey measures activity-related patient-reported outcome.
Time frame: 6 weeks, 3 months, 6 months, 9 months, 12 months, and 24 months post-operative assessment
A rating of the patient's current illness score.
Time frame: Post operative day 1, day 2, day 3, week 1, week 2, week 3, week 4, week 6, 3 months, 6 months, 9 months, 12 months, 24 months
pain rated on a 0-10 scale, 10 being worse
Time frame: 2 years
Incidence of rerupture based on clinical and radiographic (MRI) evidence
Time frame: 6 weeks, 3 months, 6 months, 9 months, 12 months, and 24 months post-operative assessment
This survey reports the impact of health on a patient's everyday life.
Time frame: 6 weeks, 3 months, 6 months, 9 months, 12 months, and 24 months post-operative assessment
A survey that evaluates patient's psychological readiness as it relates to return to sport.
Contact information is provided by the study sponsor or research team.
University of Alabama at Birmingham
Other
All Soft Tissue Quadriceps Tendon Autograft Versus Patellar Tendon Autograft in Anterior Cruciate Ligament Reconstruction: a Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06869343
Arm Injuries, Fractures, Bone
Charlottesville, Virginia, United States
View Trial DetailsNCT05381818
Arthropathy of Hip, Arthropathy of Knee
Jacksonville, Florida, United States
View Trial DetailsNCT06991205
Chronic Pain, Musculoskeletal Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT06459986
Musculoskeletal Diseases, Orthopedic Disorder
Hillerød, Denmark
View Trial Details